Post-Risk-Assessment-for-Powder-Transfer-System
Post-Risk-Assessment-for-Powder-Transfer-System
RISK ASSESSMENT
REPORT BY FMEA
Report Date
PHARMA DEVILS
QUALITY ASSURANCE DEPARTMENT
TABLE OF CONTENTS
1.0 Introduction 4
2.0 Objective 4
3.0 Scope 4
5.0 Responsibility 4
DOCUMENT APPROVAL:
This risk analysis study for the preapproval of report by following:
Production
Quality control
Reviewed by Engineering
Store
Quality assurance
Approved by Head-QA
PHARMA DEVILS
QUALITY ASSURANCE DEPARTMENT
1.0 Introduction
The “Powder Transfer System” is intended to powder transferring system in the lean phased
Vacuum conveying mode, which achieves material transfer by introducing the material into the
moving stream of air at desired rate. Conveying is achieved automatically and continues till the
material reaches its final destination & to dry the same to the final required degree in a careful
manner with assurance of product safety.
2.0 Objective
Objective of this report is to assess the risk associated with the equipment “Powder Transfer
System ” in post assessment in the manufacturing facility of Cepha Oral Block of ………….., in
line with the guidance of the Risk Management manual of ……………and ICH Q9.
3.0 Scope
The scope of this document is limited to the design, installation, operation, performance and
safety of equipment “Powder Transfer System” and define its failure mode at pre assessment in
the manufacturing facility at ……………….
Risk assessment is carried out as per FMEA (Failure mode, effects analysis) method.
5.0 Responsibility
Quality Assurance
Engineering
Production
Quality Control
Store
Background
………………..is intended to start manufacturing of solid oral facility at ………….. Risk assessment is a
part of corporate quality assurance. Post Quality Risk Assessment of “Powder Transfer System” is done to
check the system is capable of providing quality product throughout the life cycle of the drug product.
Slight 3 Slight
Major 7 Product performance severely affected, but some operability and safe
Note: Individual contributory factor for each potential failure mode shall be rated. Other scale parameters
may also be selected based on the process.
Current Control
Occurrence (O)
RPN (S x O x D)
Action Results
Detection (D)
Responsibility
Severity (s)
and TCD
Occurrence
New RPN
Detection
Potential Potential effect Potential cause/ Recommended
Severity
S.No.
Action
taken
Failure Mode (s) of failure Mechanism of failure action
Equipment may
N N N N
not function as 4 3 2 24 NA NA
A A A A
desired.
c-GMP
URS is prepared by N N N N
requirement will 7 3 1 21 NA NA
experienced A A A A
not meet
personnel with the
help of engineering ,
Design Safety measures QA & department
with respect to No or inadequate clarity Current control
Qualification Head. N N N N
operator and 4 (Knowledge) in 3 2 24 measures are NA NA
1 document A A A A
environment will preparation of URS. adequate
received is Well experienced
inadequate. not be clear. Personnel from QA,
Engineering & user
department verified
Clarity on P & DQ against URS. N N N N
ID diagram will 3 3 2 18 NA NA
A A A A
not be clear
Major
components list N N N N
6 2 2 24 NA NA
will be missed A A A A
out.
PHARMA DEVILS
QUALITY ASSURANCE DEPARTMENT
Current Control
Occurrence (O)
RPN (S x O x D)
Action Results
Detection (D)
Responsibility
Severity (s)
and TCD
Occurrence
New RPN
Detection
Potential Potential effect Potential cause/ Recommended
Severity
S.No.
Action
taken
Failure Mode (s) of failure Mechanism of failure action
Requirement of
utilities (power
N N N N
and compressed 3 4 2 24 NA NA
A A A A
air) will not be
clear.
Functional
design N N N N
Design 4 3 Well experienced 2 24 NA NA
specification will A A A A
Qualification not be available. No or inadequate clarity Personnel from QA, Current control
document (Knowledge) in Engineering & user measures are
1
received is Generally preparation of URS. department verified adequate
inadequate assembling DQ against URS. N N N N
4 4 1 16 NA NA
diagram will not A A A A
be clear
Instrument list
connected with N N N N
4 3 2 24 NA NA
equipment will A A A A
be missing
PHARMA DEVILS
QUALITY ASSURANCE DEPARTMENT
Current Control
Occurrence (O)
RPN (S x O x D)
Action Results
Detection (D)
Responsibility
Severity (s)
and TCD
Occurrence
New RPN
Detection
Potential Potential effect Potential cause/ Recommended
Severity
S.No.
Action
taken
Failure Mode (s) of failure Mechanism of failure action
Document
verification
related to design
verification, c
GMP
requirement, Well experienced
Design
Instrument & Personnel from QA,
Qualification Current control
control Inadequate knowledge or Engineering & user
document is not measures are N N N N
2 verification, 4 inadequate training to all 3 department verified 2 24 NA NA
checked and adequate A A A A
components concerned. DQ against URS.
verified
verification,
properly.
utility
verification &
safety
verification will
not be
appropriate.
Interpretation of
Installation URS along with DQ. Current control
Inadequate Inadequate information
Qualification measures are N N N N
3 Installation of 4 in IQ. 3 2 21 NA NA
document is SOP is in place for adequate A A A A
equipment
inadequate verification of IQ
document.
Interpretation of Current control
Identification of
Inadequate information URS along with DQ. measures are
major N N N N
6 in IQ. 2 2 24 adequate NA NA
components will A A A A
SOP is in place for
be missing
verification of IQ
PHARMA DEVILS
QUALITY ASSURANCE DEPARTMENT
Current Control
Occurrence (O)
RPN (S x O x D)
Action Results
Detection (D)
Responsibility
Severity (s)
and TCD
Occurrence
New RPN
Detection
Potential Potential effect Potential cause/ Recommended
Severity
S.No.
Action
taken
Failure Mode (s) of failure Mechanism of failure action
No or inadequate document.
clarity on
equipment /
N N N N
documents 3 3 2 18 NA NA
A A A A
required for
completion of
IQ.
Calibrated Installation will 6 Inadequate training 4 1 24 . Current control NA
Measuring be improper, measures are
equipment not Equipment will Ensure Physically for adequate
available at site.( not perform as the availability of
multi meter, intended equipments before N N N N
4 NA
spirit level, execution of IQ. A A A A
Tachometer)
Reference Installation will 6 Inadequate knowledge for 4 Qualification team 1 24 Current control NA
document not be improper, verification of reference will ensure measures are
available at site Equipment will documents on receipt. Physically for the adequate
during IQ. (FDS, not perform as availability of
PLC FDS, GA intended documents before
and electrical execution of IQ.
N N N N
5 drawing, NA
A A A A
installation &
Operational
manual, Material
chart with test
certificate &
Manual.)
PHARMA DEVILS
QUALITY ASSURANCE DEPARTMENT
Current Control
Occurrence (O)
RPN (S x O x D)
Action Results
Detection (D)
Responsibility
Severity (s)
and TCD
Occurrence
New RPN
Detection
Potential Potential effect Potential cause/ Recommended
Severity
S.No.
Action
taken
Failure Mode (s) of failure Mechanism of failure action
MOC Product may gets 7 1. MOC Test certificate 4 Procedure is in place 2 56 Molybdenum kit Engineering,
verification not contaminated not provided by vendor. for verification to be procured
done during IQ ( 2. Molybdenum Kit Not during IQ.
6
For contact and available
non contact parts
)
Equipment name Equipment will 4 Equipment name plate not 3 Procedure is in place 2 24 Controlled NA NA N N N N
plate not not be identified. provided by vendor for verification measures are in A A A A
7 available during during IQ. place
IQ
Current Control
Occurrence (O)
RPN (S x O x D)
Action Results
Detection (D)
Responsibility
Severity (s)
and TCD
Occurrence
New RPN
Detection
Potential Potential effect Potential cause/ Recommended
Severity
S.No.
Action
taken
Failure Mode (s) of failure Mechanism of failure action
Procedure are in
place for verification
during OQ
Temperature Accuracy of 7 Inadequate 3 Procedure are in 1 21 Controlled NA NA N N N N
sensors are not temperature will knowledge/training place for verification measures are in A A A A
12 calibrated not be achieved during OQ place
Current Control
Occurrence (O)
RPN (S x O x D)
Action Results
Detection (D)
Responsibility
Severity (s)
and TCD
Occurrence
New RPN
Detection
Potential Potential effect Potential cause/ Recommended
Severity
S.No.
Action
taken
Failure Mode (s) of failure Mechanism of failure action
Current Control
Occurrence (O)
RPN (S x O x D)
Action Results
Detection (D)
Responsibility
Severity (s)
and TCD
Occurrence
New RPN
Detection
Potential Potential effect Potential cause/ Recommended
Severity
S.No.
Action
taken
Failure Mode (s) of failure Mechanism of failure action
168
control functions preparation will knowledge/training for Preparation of prepared for
verification test not be possible operating the equipment. Recipe is available in preparation of
not done. operational manual Recipe
Equipment will 8 Recipe is not prepared 4 Procedure for 6 SOP will be Production
192
not be under through password Preparation of prepared for
password protection Recipe is available in preparation of
protection operational manual password
protection
144
appropriate mode knowledge/training for Operational checks prepared for
like Manual, operating the equipment during OQ. proper selection
Auto, Recipe, recipe for product
Maintenance, ,Maintenance,
wash will not be wash
possible
System will not 6 System run in Manual 4 Activity will 1 24 System should NA NA N N N N
give any alarm Mode performed by not run in manual A A A A
during Trained personnel. mode after
malfunctioning. validation,
accordingly SOP
will be prepared.
PHARMA DEVILS
QUALITY ASSURANCE DEPARTMENT
Current Control
Occurrence (O)
RPN (S x O x D)
Action Results
Detection (D)
Responsibility
Severity (s)
and TCD
Occurrence
New RPN
Detection
Potential Potential effect Potential cause/ Recommended
Severity
S.No.
Action
taken
Failure Mode (s) of failure Mechanism of failure action
120
prepared for performance of knowledge/training for Preparation of prepared for
Product, Wash, equipment will operating the equipment Recipe is available in recipe
maintenance not be possible operational manual preparation for
18
cycle. Product, Wash,
`maintenance
cycle.
Current Control
Occurrence (O)
RPN (S x O x D)
Action Results
Detection (D)
Responsibility
Severity (s)
and TCD
Occurrence
New RPN
Detection
Potential Potential effect Potential cause/ Recommended
Severity
S.No.
Action
taken
Failure Mode (s) of failure Mechanism of failure action
Current Control
Occurrence (O)
RPN (S x O x D)
Action Results
Detection (D)
Responsibility
Severity (s)
and TCD
Occurrence
New RPN
Detection
Potential Potential effect Potential cause/ Recommended
Severity
S.No.
Action
taken
Failure Mode (s) of failure Mechanism of failure action
No Fluidization Product will not 7 Insufficient amount of air 5 Procedure is in place 2 70 PQ protocol & QA,
in the product meet the is available. for verification preventive Production,
specification during OQ maintenance
PQ protocol is not schedule will be Engineering,
prepared. prepared after
successful
Preventive maintenance completion of
schedule is not prepared. OQ to check
25 proper
fluidization in the
product
No dedicated Product will be 8 Insufficient FBD finger 4 Decision has been 2 64 Dedicated
FBD finger bag contaminated bags available taken for product product specific
26 specific to the dedicated FBD finger FBD finger bag
product bag to be procured
PHARMA DEVILS
QUALITY ASSURANCE DEPARTMENT
Action Results
Remarks
Action Taken Severity Occurrence Detectability RPN
PHARMA DEVILS
QUALITY ASSURANCE DEPARTMENT
………………………………………………………………………………………………………………
………………………………………………………………………………………………………………
………………………………………………………………………………………………………………
………………………………………………………………………………………………………………
………………………………………………………………………………………………………………
………………………………………………………………………………………………………………
………………………………………………………………………………………………………………
………………………………………………………………………………………………………………
………………………………………………………………………………………………………………
………………………………………………………………………………………………………………
………………………………………………………………………………………………………………
………………………………………………………………………………………………………………
………………………………………………………………………………………………………………
………………………………………………………………………………………………………………
………………………………………………………………………………………………………………
………………………………………………………………………………………………………………
………………………………………………………………………………………………………………
………………………………………………………………………………………………………………
………………………………………………………………………………………………………………
(Sign/Date)
PHARMA DEVILS
QUALITY ASSURANCE DEPARTMENT
Summary: .....……………………………………………………………………………………………
………………………………………………………………………………………………………………
………………………………………………………………………………………………………………
………………………………………………………………………………………………………………
………………………………………………………………………………………………………………
………………………………………………………………………………………………………………
………………………………………………………………………………………………………………
………………………………………………………………………………………………………………
Conclusion: ………………………………………………………………………………………………
………………………………………………………………………………………………………………
………………………………………………………………………………………………………………
………………………………………………………………………………………………………………
………………………………………………………………………………………………………………
………………………………………………………………………………………………………………
………………………………………………………………………………………………………………
………………………………………………………………………………………………………………
………………………………………………………………………………………………………………
PHARMA DEVILS
QUALITY ASSURANCE DEPARTMENT
The final report shall be signed after identifying all the risks and critical control parameters. All the reports
or documents have been attached to the respective report (if applicable).
Signature in the block below indicates that all the control measures taken are documented and have been
reviewed and found to be acceptable.
Quality assurance
Production
Quality control
Engineering
Store
Head-QA